Guest guest Posted September 2, 2008 Report Share Posted September 2, 2008 This bit came in on some law firm spam, but I felt it was newsworthy:Heart Medications RecalledPatients with Renal Failure Need to Take Heed Heart medications are an essential part of life for millions of people, particularly those who have dealt with heart failure and/or those who suffer from irregular heartbeats. The demand for these medications is at an all-time high, and drug companies are churning out new medications and higher volumes of these medications than ever before. Unfortunately, a hyper-speed market can lead to problems, and that appears to be the case with one form of heart medication sold under several names, all of which have recently been recalled by the companies responsible. The danger posed by a consistent manufacturing defect is particularly high for those patients with renal failure, and each of the components of this issue is detailed below. The Drugs The drugs are sold under different brand names, but they are essentially the same product with a similar active ingredient. They are as follows: DigitekBertekUDL The Companies The companies responsible for either manufacturing these drugs or distributing them appear below: Actavis Totowa LLC – DigitekMylan Pharmaceuticals, Inc. – BertekUDL Laboratories, Inc. – UDL The Problem While the companies and brand names may be different, the problem is consistent. Essentially, some of the pills that are manufactured are being released with twice the thickness that they should have, which means that unsuspecting patients are taking twice the dose as intended. When this happens, a condition known as digitalis toxicity results, which is presented by symptoms that include: NauseaVomitingDizzinessLow Blood PressureBradycardia This is an extremely dangerous condition, which is why these drugs are being pulled from the market. If you have suffered as a result of using these drugs, contact a defective drugs attorney immediately.Talk to your Friends via . Find Out How Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 2, 2008 Report Share Posted September 2, 2008 If these companies do not have the ability of micrometering doses and quality control of their systems, all their manufacturing licenses should be revoked. In what country are these drugs being made? Quality control procedures need to be in place for all imported drugs.--- On Tue, 9/2/08, Rebecca Price <raprice49 wrote: Rebecca Price <raprice49 heart medication recallhealth_and_healing Date: Tuesday, September 2, 2008, 1:28 PM This bit came in on some law firm spam, but I felt it was newsworthy: Heart Medications RecalledPatients with Renal Failure Need to Take HeedHeart medications are an essential part of life for millions of people, particularly those who have dealt with heart failure and/or those who suffer from irregular heartbeats. The demand for these medications is at an all-time high, and drug companies are churning out new medications and higher volumes of these medications than ever before.Unfortunately, a hyper-speed market can lead to problems, and that appears to be the case with one form of heart medication sold under several names, all of which have recently been recalled by the companies responsible. The danger posed by a consistent manufacturing defect is particularly high for those patients with renal failure, and each of the components of this issue is detailed below.The DrugsThe drugs are sold under different brand names, but they are essentially the same product with a similar active ingredient. They are as follows: Digitek Bertek UDLThe CompaniesThe companies responsible for either manufacturing these drugs or distributing them appear below: Actavis Totowa LLC – Digitek Mylan Pharmaceuticals, Inc. – Bertek UDL Laboratories, Inc. – UDLThe ProblemWhile the companies and brand names may be different, the problem is consistent. Essentially, some of the pills that are manufactured are being released with twice the thickness that they should have, which means that unsuspecting patients are taking twice the dose as intended. When this happens, a condition known as digitalis toxicity results, which is presented by symptoms that include: Nausea Vomiting Dizziness Low Blood Pressure BradycardiaThis is an extremely dangerous condition, which is why these drugs are being pulled from the market. If you have suffered as a result of using these drugs, contact a defective drugs attorney immediately. Talk to your Friends via . Find Out How Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 2, 2008 Report Share Posted September 2, 2008 My doctor called me more then 4 months ago in regard to the Digoxin that I take to regulate my heartbeat. Some tablets contained double the prescribed dose of medication which could slow the heartbeat to a dangerous if not fatal level. Most medications are coming out of China now and are not listed as such. It is another case of "buyer beware".--- On Tue, 9/2/08, Tony De Angelis <tntstuart wrote: Tony De Angelis <tntstuartRe: heart medication recall Date: Tuesday, September 2, 2008, 3:34 PM If these companies do not have the ability of micrometering doses and quality control of their systems, all their manufacturing licenses should be revoked. In what country are these drugs being made? Quality control procedures need to be in place for all imported drugs.--- On Tue, 9/2/08, Rebecca Price <raprice49 (AT) hotmail (DOT) com> wrote: Rebecca Price <raprice49 (AT) hotmail (DOT) com>[Health_and_ Healing] heart medication recallhealth_and_healingTuesday, September 2, 2008, 1:28 PM This bit came in on some law firm spam, but I felt it was newsworthy: Heart Medications RecalledPatients with Renal Failure Need to Take HeedHeart medications are an essential part of life for millions of people, particularly those who have dealt with heart failure and/or those who suffer from irregular heartbeats. The demand for these medications is at an all-time high, and drug companies are churning out new medications and higher volumes of these medications than ever before.Unfortunately, a hyper-speed market can lead to problems, and that appears to be the case with one form of heart medication sold under several names, all of which have recently been recalled by the companies responsible. The danger posed by a consistent manufacturing defect is particularly high for those patients with renal failure, and each of the components of this issue is detailed below.The DrugsThe drugs are sold under different brand names, but they are essentially the same product with a similar active ingredient. They are as follows: Digitek Bertek UDLThe CompaniesThe companies responsible for either manufacturing these drugs or distributing them appear below: Actavis Totowa LLC – Digitek Mylan Pharmaceuticals, Inc. – Bertek UDL Laboratories, Inc. – UDLThe ProblemWhile the companies and brand names may be different, the problem is consistent. Essentially, some of the pills that are manufactured are being released with twice the thickness that they should have, which means that unsuspecting patients are taking twice the dose as intended. When this happens, a condition known as digitalis toxicity results, which is presented by symptoms that include: Nausea Vomiting Dizziness Low Blood Pressure BradycardiaThis is an extremely dangerous condition, which is why these drugs are being pulled from the market. If you have suffered as a result of using these drugs, contact a defective drugs attorney immediately. Talk to your Friends via . Find Out How Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.